rare anatomical localizations of hydatid cysts 2020 2025 narrative review of presentation imaging and management

Original title: “Rare anatomical localizations of hydatid cysts (2020-2025): Narrative review of presentation, imaging, and management.”

description of the second scale developed and eyed sinocyclocheilus cypriniformes cyprinidae species from south guizhou china with evolutionary implications

Original title: “Description of the second scale-developed and eyed Sinocyclocheilus (Cypriniformes: Cyprinidae) species from South Guizhou, China, with evolutionary implications.”

comprehensive multimodal imaging of quadricuspid pulmonary valves morphology function and mid term prognosis

Original title: “Comprehensive multimodal imaging of quadricuspid pulmonary valves: morphology, function, and mid-term prognosis.”

lipids in kidney diseases from systemic imbalance to intrarenal alterations of cellular lipid metabolism in rare and common kidney diseases

Original title: “Lipids in kidney diseases: from systemic imbalance to intrarenal alterations of cellular lipid metabolism in rare and common kidney diseases.”

cooperative role of cd81 with gpr56 and collagen iii in cortical formation

Original title: “Cooperative role of CD81 with GPR56 and collagen III in cortical formation.”

short report targeted analysis of whole exome sequencing data in indian cryptogenic stroke patients

Original title: “Short report: Targeted analysis of whole exome sequencing data in Indian cryptogenic stroke patients.”

unmasking of sglt2 inhibitor associated ketoacidosis after initiation of mechanical ventilation with consecutive cardiopulmonary resuscitation and extracorporeal life support a case report

Original title: “Unmasking of SGLT2 inhibitor associated ketoacidosis after initiation of mechanical ventilation with consecutive cardiopulmonary resuscitation and extracorporeal life support: A case report.”

persistent hiccups as an atypical sole manifestation of st segment elevation myocardial infarction an interesting case report

Original title: “Persistent Hiccups as an Atypical Sole Manifestation of ST-Segment Elevation Myocardial Infarction: An Interesting Case Report.”

sinus bradycardia as an atypical presentation of severe hypercalcemia a case report and a literature review

Original title: “Sinus bradycardia as an atypical presentation of severe hypercalcemia: a case report and a literature review.”

experiences with integrating medical terminologies into user interfaces for a decision support system for primary care conceptual and development study

Original title: “Experiences With Integrating Medical Terminologies Into User Interfaces for a Decision Support System for Primary Care: Conceptual and Development Study.”

surgical outcomes of occipitocervical fusion for metastatic disease at the craniocervical junction 24 years of experience at a tertiary cancer referral center

Original title: “Surgical outcomes of occipitocervical fusion for metastatic disease at the craniocervical junction: 24 years of experience at a tertiary cancer referral center.”

emergence of a novel cefotaxime and ciprofloxacin resistant strain of serogroup y neisseria meningitidis sequence type 23 clonal complex in china

Original title: “Emergence of a novel cefotaxime- and ciprofloxacin-resistant strain of serogroup Y Neisseria meningitidis sequence type 23 clonal complex in China.”

giant polycystic liver disease with thoracic involvement an anaesthesia and surgical challenge in liver transplantation

Original title: “Giant polycystic liver disease with thoracic involvement: an anaesthesia and surgical challenge in liver transplantation.”

axitinib and long acting octreotide in advanced extrapancreatic neuroendocrine tumors a randomized double blind placebo controlled phase iii clinical trial axinet getne 1107

Original title: “Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).”

epstein barr virus positive diffuse large b cell lymphoma presenting as pyrexia of unknown origin complicated by paraneoplastic neurological syndrome

Original title: “Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma Presenting as Pyrexia of Unknown Origin Complicated by Paraneoplastic Neurological Syndrome.”

unveiling the invisible a case of canine diffuse microscopic pancreatic adenocarcinoma with normal imaging and gross appearance of the pancreas complicated by sterile peritonitis and disseminated intravascular coagulation

Original title: “Unveiling the Invisible: A Case of Canine Diffuse Microscopic Pancreatic Adenocarcinoma With Normal Imaging and Gross Appearance of the Pancreas Complicated by Sterile Peritonitis and Disseminated Intravascular Coagulation.”

In this episode of Denatured, you'll be listening to Jane Hughes, President of R&D and Co-founder of Verdiva Bio, and Jon Rees, CEO and Co-founder of MitoRx Therapeutics. We'll discuss next-generation obesity solutions tackling GLP-1's muscle loss and adherence challenges, through innovative muscle preservation, oral administration and combination therapy.

Original title: “Redefining Obesity Treatment Beyond GLP-1 Limits”

The Global Sickle Cell Disease and thalassemia gene therapy market size was US 83 87 Million in 2024 and is expected to reach US 380 42 Million by 2033 growing at a CAGR of 18 4 during the forecast period ... Press release - DataM intelligence 4 Market Research LLP - Sickle Cell Disease and ?-Thalassemia Gene Therapy Market Set for Explosive Growth to US$ 380.42 Million by 2033, Led by North America's 48.5% Market Share - published on openPR.com Introduction Sickle Cell Disease (SCD) is a group of inherited blood disorders caused by mutations in the hemoglobin gene, leading to abnormally shaped red blood cells. These "sickle" shaped cells result in chronic anemia, vaso-occlusive crises, organ damage, and reduced life expectancy. The Global Sickle Cell Disease and β-thalassemia gene therapy market size was US$ 83.87 Million in 2024 and is expected to reach US$ 380.42 Million by 2033, growing at a CAGR of 18.4% during the forecast period 2025-2033. Market expansion is propelled by advancements in gene-editing technologies like CRISPR/Cas9 and lentiviral vectors, enabling precise genetic corrections and potential cures. Rising clinical trials demonstrate long-term safety and efficacy, while regulatory approvals for therapies such as CASGEVY, LYFGENIA, and ZYNTEGLO boost adoption and investment. Increasing disease prevalence affecting over 6 million globally, along with partnerships accelerating commercialization, further fuel demand. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/sickle-cell-disease-scd-and-beta-thalassemia-gene-therapy-market?ram Key Industry Developments United States: ✅ February 2026: CRISPR Therapeutics highlighted ongoing momentum in CASGEVY launch for SCD and β-Thalassemia, noting strong patient demand, over 50 activated authorized treatment centers, and robust payer support including a new CMS outcomes-based agreement for equitable access.

Original title: “Sickle Cell Disease and β-Thalassemia Gene Therapy Market Set for Explosive Growth to US$ 380.42 Million by 2033, Led by North America's 48.5% Market Share”

pedunculated hemangioma in the left ventricle case report in an asymptomatic young patient

Original title: “Pedunculated Hemangioma in the Left Ventricle: Case Report in an Asymptomatic Young Patient.”

marked regression of calcinosis with canakinumab in hyperphosphatemic familial tumoral calcinosis

Original title: “Marked regression of calcinosis with canakinumab in hyperphosphatemic familial tumoral calcinosis.”